{"disease":{"id":"moderate-to-severe-chronic-noncancer-pain","name":"moderate to severe chronic noncancer pain"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02603705","title":"Safety and Tolerability of Egalet-002 in Patients With Moderate-to-Severe Chronic Noncancer Pain","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":281,"lead_sponsor_name":"Egalet Ltd","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}